Although NCX3 has been shown to exhibit neuroprotective effects in certain neurodegenerative diseases, such as Alzheimer's disease, it is primarily expressed in central neurons, whereas its expression in DRG is much lower than that of NCX1. Here, SLC8A3 is linked to neurodegenerative disease.